2 ms·
The fact that the SENS approach can even lead to "made for investors", plausibly-viable biotech spinoffs is, if anything, a validation of its scientific plausib
by zozbot234 5y ago
The fact that the SENS approach can even lead to "made for investors", plausibly-viable biotech spinoffs is, if anything, a validation of its scientific plausibility. Don't get me wrong, you could fairly describe it as a niche, fringe, unpopular approach and perhaps discount it on that basis, but it's at least not so fringe as to be entirely useless.
- jacquesm 5y agoNo, it's mostly a proof of the fact that investors do not usually have a good grasp of what they are investing in. See also: Theranos, Moller, uBeam and many others besides. And in the case of de Grey specifically, that Pascal's wager is alive and well.